Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Roche Holding Ltd (OP: RHHBF ) 363.17 +8.79 (+2.48%) Streaming Delayed Price Updated: 3:08 PM EDT, Aug 30, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Roche Holding Ltd < Previous 1 2 3 4 5 6 7 Next > WHO Recommends Against Roche, GSK's COVID-19 Therapies Rendering Them Obsolete September 16, 2022 Due to the lack of effectiveness against omicron and the variants, World Health Organization (WHO) no longer recommends using two COVID-19 antibody therapies. Via Benzinga No More Free COVID-19 At-Home Tests, Federal Government Says August 29, 2022 CNBC reported that the federal government is set to suspend its offer of free at-home COVID-19 tests by Friday, September 2, without congressional au Via Benzinga Citi Is Bullish On This Large Pharma Stock On Upcoming Data Readout From Diabetes Candidate August 25, 2022 Citi has increased peak risk-adjusted Eli Lilly And Co's (NYSE: LLY) tirzepatide forecasts (diabetes/ obesity/NASH) to more than $25 billion (previously $15 billion, consensus of around $16 billion). Via Benzinga FDA Approves Expanded Use Of Roche's Influenza Treatment August 12, 2022 Via Benzinga China-Based Jemincare Inks Prostate Cancer Drug Pact With Roche's Genentech August 18, 2022 Via Benzinga Roche's Polivy Combo Regime Under FDA Review For Type Of Blood Cancer August 16, 2022 Via Benzinga Amgen's Lumakras/Keytruda/Tecentriq Combo Data Flags Safety Concern August 08, 2022 Via Benzinga Poseida Shares Rally As Roche Takes Next Big Step Into Allogeneic CAR-T Field August 03, 2022 Via Benzinga Regeneron's Price Target Cut On Dim Prospects For Its Flagship Eye Product July 25, 2022 Via Benzinga Daily Biotech Pulse: Liver Disease-Focused Gene Therapy Pact, Assembly Bio Stops HBV Infection Trial, X4 Pharma Looks For Partners July 21, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Via Benzinga Roche's Long-Time CEO Passes Baton, Higher Diagnostics, Medicine Sales Lift 1H Sales & Profit July 21, 2022 Via Benzinga Roche Launches Dual Antigen & Antibody Hepatitis C Diagnostic Test July 18, 2022 Via Benzinga New Data Reinforce Favorable Safety, Efficacy Of Roche's Hemlibra For Hemophilia A July 11, 2022 Via Benzinga Sarepta Reports One Heart Inflammation Case In Duchenne Gene Therapy Trial July 06, 2022 Via Benzinga The Daily Biotech Pulse: FDA Decision On Biogen Alzheimer's Drug Due In January, FDA Reviews Roche's Lymphoma Candidate, Rare Pediatric Tag For Kazia's Pediatric Brain Cancer Candidate July 06, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Via Benzinga Roche-AC Immune's Crenezumab Fails To Show Benefit In Sub-Set Of Alzheimer's Patients June 16, 2022 Via Benzinga Early Data Shows BioNTech's Personalized Therapy Safe In Pancreatic Cancer Patients June 06, 2022 Via Benzinga Seagen Posts Encouraging Data From Tucatinib Combo Trial In Colorectal Cancer May 23, 2022 Via Benzinga Genentech's Tiragolumab/Tecentriq Fails On Progression Free Survival In PD-L1-High Metastatic Lung Cancer May 11, 2022 Genentech, a unit of Roche Holdings AG (OTC: RHHBY), announced results from its Phase 3 SKYSCRAPER-01 study, evaluating tiragolumab in PD-L1-high locally advanced or metastatic non-small cell lung... Via Benzinga Roche Releases More Evrysdi Data For Very Young Infants With SMA April 29, 2022 Via Benzinga Roche's CEO Warns Russia-Ukraine War Causing Problems For Multiple Sclerosis Trials April 25, 2022 The development of Roche Holdings AG's (OTC: RHHBY) multiple sclerosis candidate fenebrutinib is negatively impacted by Russia's ongoing invasion of Ukraine. Via Benzinga COVID-19 Tests Boost Roche's Q1 Sales, Reaffirms FY22 Outlook April 25, 2022 Via Benzinga EMA' Advisory Committee Recommends Approval For Roche's Two Cancer Drugs April 22, 2022 Via Benzinga FDA Warns Against Relying On Screening Tests For Prenatal Diagnosis April 20, 2022 The U.S. FDA is warning that noninvasive prenatal screening (NIPS) tests may provide false results, such as stating a fetus may have a genetic abnormality when the fetus was... Via Benzinga Read Why Pliant Therapeutics Shares Are Soaring Today April 13, 2022 Pliant Therapeutics Inc (NASDAQ: PLRX) says that with just two FDA-approved Idiopathic Pulmonary Fibrosis drugs, it believes that is a high unmet need. Via Benzinga Genentech's Ocrevus Shows Benefit In Disability Progression & Cognitive Decline In Multiple Sclerosis April 04, 2022 Via Benzinga FDA Grants Priority Review To Roche's Actemra For Hospitalized COVID-19 Adults April 04, 2022 Via Benzinga Roche's Tiragolumab Immunotherapy Flunks In Late-Stage Lung Cancer Trial March 30, 2022 Roche Holding AG's (OTC: RHHBY) Phase 3 SKYSCRAPER-02 study in extensive-stage small-cell lung cancer (ES-SCLC) Via Benzinga Drug makers, Scientists Working For Long COVID Treatments: Reuters March 25, 2022 Researchers and drugmakers, including those who have launched antiviral pills and monoclonal antibodies for COVID-19, are having early discussions about targeting Long COVID, Via Benzinga Roche's Evrysdi Shows Long-Term Efficacy, Safety In Broader Spinal Muscular Atrophy Population March 16, 2022 Via Benzinga < Previous 1 2 3 4 5 6 7 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.